The FDA approval was based on data from a randomized, multi-arm, controlled clinical trial (n=1,879) that showed using Tegaderm CHG IV Securement Dressing lowered CRBSI by 60% in patients with ...

Tegaderm CHG IV securement dressing (3M) is a sterile, semi-permeable polyurethane adhesive dressing with an integrated gel pad containing 2% w/w chlorhexidine gluconate (CHG). It is used to secure ...

3M Tegaderm CHG Chlorhexidine Gluconate IV Securement Dressing (3M). 3M’s Tegaderm CHG Chlorhexidine Gluconate IV Securement Dressing decreases catheter-related bloodstream infections and ...

ST. PAUL, Minn.--(BUSINESS WIRE)--Every IV catheter poses potential for serious and costly complications, including those occurring from commonly used peripheral intravenous (PIV) catheters ...

The medical technology guidance advises using the 3M Tegaderm CHG IV securement dressing for critically ill patients who need a central venous or arterial catheter in intensive care or high dependency ...

Dubai, UAE, 29 October 2009 &ndash 3M Health Care, a division of 3M, the innovative technology company that produces thousands of products for dozens of diverse industries, recently launched the first ...

3M Health Care recently announced the launch of its Tegaderm Matrix Dressing with PHI ... diabetic ulcers, pressure ulcers (stages II-IV) and venous stasis ulcers. MCKNIGHT’S LONG-TERM CARE ...

The company proposed that using the 3M Tegaderm CHG IV securement dressing (Tegaderm CHG) would not result in changes to the current care pathway or need additional resources. The External Assessment ...

The medical technology guidance advises using the 3M Tegaderm CHG IV securement dressing for critically ill patients who need a central venous or arterial catheter in intensive care or high dependency ...